Biolase (NASDAQ: BIOL) is a medical device company that develops, manufactures, markets and sells laser systems for dentistry and medicine and also markets, sells and distributes dental imaging equipment. The company’s proprietary laser products incorporate approximately 250 patented and 90 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices and are designed to deliver the best results for dentists and patients. BIOLASE’s principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 31,200 laser systems to date in over 90 countries around the world. Laser products under development address the company’s core dental market and other adjacent medical and consumer markets. For more information, visit the company’s website at www.biolase.com